An interventional study of omega-3 fatty acids and placebo in Hot Flashes, Fatty Acids and Menopause, sponsored by Vivatech. Completed at 1 site in France. Open to female participants aged 35 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-12-09.
Sponsored by Vivatech · Not applicable, Interventional, and Treatment
The main objective is to evaluate the effects of omega-3 fatty acids on hot flashes frequency.
293 studies on the registry are indexed under Hot Flashes; 52 are open to participants now.
This study's enrollment of 136 is above the median of 90 across 262 interventional studies indexed under Hot Flashes.
Browse Hot Flashes studies →Vivatech is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
3 capsules each day during 8 weeks
Dietary Supplement: omega-3 fatty acids
3 capsules each day during 8 weeks
Dietary Supplement: placebo
highly dosed in EPA
Also known as: groupe actif
hot flashes frequency
ANOVA by repeated measures
Time frame: 1 to 8 week
hot flashes frequency difference
difference betwwen week8 and week4 and week0
Time frame: 4 week and 8 week
diurnal hot flashes
ANOVA and difference
Time frame: week 1 to 8
night hot flashes
ANOVA and difference
Time frame: week 1 to 8
vasomotors disorders
ANOVA and differences
Time frame: week 1 to week 8
Pittsburgh Sleep Quality Index (PSQI)
sleep quality
Time frame: week 0 and week 8
HFRDIS
quality of life
Time frame: week 0 and week 8
The Menopause-Specific Quality of Life (MENQOL)
quality of life
Time frame: week 0 and week 8
Weight
Time frame: week 0 and week 8
fatty acids dosage
fatty acids dosage
Time frame: week 0 and week 8
number of adverse events
Time frame: week 0 to week 8
This study is completed, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Omega-3 fatty acid